Earlybird Venture Capital’s Post

What are the 𝐤𝐞𝐲 𝐩𝐡𝐚𝐫𝐦𝐚 𝐝𝐢𝐠𝐢𝐭𝐚𝐥 𝐡𝐞𝐚𝐥𝐭𝐡 𝐧𝐞𝐰𝐬 & 𝐩𝐚𝐫𝐭𝐧𝐞𝐫𝐬𝐡𝐢𝐩𝐬 of the first semester of 2024? A few weeks ago, I stumbled upon this amazing work by Gary Monk on LinkedIn, showcasing the main digital pharma collaborations in a single image. Brilliant! 👏 But let's be honest, this is just the tip of the iceberg. 🌐 What other groundbreaking partnerships are out there? 💡 Want to be part of the next collaboration map? 🤝 Let's inspire more collaborations together! 🚀 #digitalpharma #pharmaindustry #collaboration #innovation #healthcare

New approaches, fresh thinking, creativity and stepping outside our comfort zones - wholeheartedly embraced by our Human Pharma Leaders last week, as we spent some time offsite focusing on business transformation and our path to 2035. I recognise that the pace of change has never been so great, so at Boehringer Ingelheim we’re not standing still. The needs of patients and healthcare systems continues to intensify and become ever more complex. We’re focused on our transformational journey to meet those challenges. But we also know how to have fun along the way! #LifeForward #BoehringerIngelheim #OurPathTo2035

From the point of view of intangible assets, Key Alliance Capital is one of the pillars of the value of Intellectual Capital 🙌🔝🍀 It is very important to work to strengthen it every day🙌

🧠💡 What are we providing in our Vickino Intelligence solution? 🏥 Whether you're an investor, a company, or part of regulatory authorities, you need timely, relevant, and curated information tailored to your specific needs. In today's rapidly evolving healthcare landscape, staying informed is key to success. 🔍 We create customized intelligence reports based on market intelligence, scientific watch from monitoring publications and registered trials, regulatory updates, deal tracking and KOL/DOLs monitoring. 💼 Our reports are offered with contextualization to align with your business goals. Plus, our team of experts is always ready to discuss results and provide insights to help you make informed decisions. 📈 Don't fall behind in the fast-paced world of healthcare innovation, partner with Vickino Intelligence and stay ahead of the curve! #HealthcareInnovation #MarketIntelligence #Vickino #DigitalHealth

Exploring strategic healthcare innovations and challenges in LATAM and APAC with industry expert, Marc Yates. In a recent interview with BioPharma APAC, Marc Yates, Senior Director, shares his extensive experience and unique insights into the evolving healthcare landscapes of Latin America and Asia-Pacific regions. How can you bridge the gap between emerging markets and developed healthcare systems? Read the full interview to learn more: https://lnkd.in/e5D_E47Y #Healthcare #APAC #LATAM #EmergingMarkets

A four-member expert panel has been announced today to lead the Federal Government’s strategic review into Australia’s research and development performance. 🔬 The review will assess how a more purposeful approach to R&D can drive economic growth and productivity. ANDHealth is particularly pleased to see the focus on commercialisation, aligning with our commitment to supporting the entire commercialisation pathway – from ‘idea to exit’. Key opportunities to be explored in the review include: ▪️ Maximising the value of existing R&D investments. ▪️ Strengthening the linkages between research and industry. ▪️ Supporting the achievement of national priorities. ▪️ Driving greater R&D investment. ▪️ Uplifting Australia’s overall R&D intensity. A special congratulations to Kate Cornick on her appointment to the panel. Kate is a supporter of ANDHealth and key advocate for the sector through her work as CEO of LaunchVic.

🚨 Pharma Executives: Are You Missing Half the Workforce? 🚨 The healthcare ecosystem is evolving, and so should our approach to collaboration. 🏥💊 For the past 30 years, "multidisciplinary teams" has primarily meant frontline professionals working together. But as Dr Jonathan Oldershaw highlights, the real opportunity lies in seeing the entire healthcare ecosystem as the multidisciplinary team—Pharma, clinicians, digital innovators, policymakers, and beyond. 🌐 This isn't just about marketing—it’s about creating partnerships that: 👉 Build trust 🤝 👉 Educate on health economics 📚 👉 Deliver better patient outcomes ❤️ In a world of ageing populations, rising costs, and shrinking budgets, we can no longer afford siloed approaches. It’s time to think differently: Jono challenges us to reimagine the way we work together. Let’s start the conversation. How can we make this vision a reality? 👇 🎥 Catch the full episode on YouTube to hear his story! https://lnkd.in/geFbGQzX

⏰ 22 May | 9.30 CEST | The healthcare of tomorrow: assessing the innovation landscape in Europe 🔈 Join our Critical Thinking Live next week with Monica Shaw, Senior Vice President of European Markets at Bristol Myers Squibb! ⤵ Find out more below. #CriticalThinkingLive #HealthInnovation #EU4Health

🤝You want to partner with #Pharma in #DigitalHealth⁉️See👇 Few hints from Pharma leaders #LIVE from HLTH Europe: Stephen R. Malin Johansson Lisa Banks, PhD, MBA. Aquil Harjivan moderated by Anish Shindore (just arrived by 🚴). None of the panelists wants to crack digital health alone 🎉🥳👏 BUT you should: 👉 Understand the real problem you try to tackle first (Malin) 👉 Who is the decision maker at Pharma? Ask upfront and find the right contact to partner with (Malin) 👉 Understand where the Pharma organization is in terms of readiness and try to bring the cross-functional team along (Stephen) 👉 There is a lot of back and forth discussions and piloting between Pharma and ventures („Teenage love affair“) (Lisa) …but at some point you either „marry“ or „break-up“ (my personal addition to the bullet) 👉 Do your homework, understand how Pharma operates, what the challenges are before you reach out (Stephen and Lisa) 👉Do not overpromise - Stay true to the real value of your product - what is working and what not (Stephen) 👉 Partnership require also sharing the risk of being not successful. Are risk-sharing business models an option ? (Malin) Message conveyed 👍

👨⚕️ Carlsquare x Frontiers Health 💻 On October 17, Carlsquare Managing Partner Caspar Graf Stauffenberg will join CONVEMA Versorgungsmanagement GmbH, an IQVIA business, CEO Dr. Susan Niemeyer on stage at the Frontiers Health conference in Berlin. Come along to learn: 👉 Why a well-prepared exit strategy allows founders to engage with multiple potential buyers and ultimately achieve higher valuations on more favorable terms 👉 Why being exit-ready also preserves founders’ freedom to choose the right path forward, ensuring the company is positioned attractively to different types of acquirers 👉 Practical strategies for maximizing your company’s exit readiness No one knows more than Caspar about exit readiness in the healthcare industry. As CEO he led two life sciences firms through successful exits before moving into M&A, where he has advised on countless additional healthcare transactions. Frontiers Health is one of the premier global health innovation events, with a strong focus on digital therapies, breakthrough technologies, healthcare transformation, investments, and ecosystem development. You can sign up for the conference, enabling you to attend Caspar’s and Susan’s masterclass, using the link below 👇 https://lnkd.in/dNN4MMd #frontiershealth #manda #healthtech #digitalhealth